Sesterhenn Andreas M, Teymoortash Afshin, Folz Benedikt J, Werner Jochen A
Department of Otolaryngology, Head & Neck Surgery, Philipps-University of Marburg, Germany.
Acta Oncol. 2005;44(1):59-64. doi: 10.1080/02841860510007431.
In the industrialized nations of the Western hemisphere the age group beyond 75 years will grow steadily, requiring special attention by medical professionals in the future. With regard to these expectations 40 patients, beyond the age of 75 and who were first diagnosed to suffer from squamous cell carcinoma of the upper aerodigestive tract, were analysed.
Forty patients diagnosed and treated between 1998 and 2003 for head and neck squamous cell carcinoma (HNSCC) were analysed.
Laryngeal carcinoma was noted in 80% of the patients. All types of treatment were tolerated well. Patient compliance was generally good and the rate of complications was low.
The results of the present study show that HNSCC in elderly patients should be treated with curative intention. Age itself should never be a sole factor in deciding which curative therapy should be undertaken. Exceptions could be made in patients with severe general comorbidity.
在西半球的工业化国家,75岁以上的年龄组将稳步增长,未来需要医学专业人员给予特别关注。基于这些预期,对40名75岁以上且首次被诊断患有上消化道鳞状细胞癌的患者进行了分析。
对1998年至2003年间诊断并治疗的40例头颈部鳞状细胞癌(HNSCC)患者进行了分析。
80%的患者被诊断为喉癌。所有类型的治疗耐受性良好。患者依从性总体良好,并发症发生率较低。
本研究结果表明,老年患者的头颈部鳞状细胞癌应以治愈为目的进行治疗。年龄本身绝不应该是决定采用何种治愈性治疗的唯一因素。对于有严重全身合并症的患者可以例外。